• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

γ干扰素和长春新碱的同时应用抑制原位神经母细胞瘤小鼠模型中的肿瘤生长。

Concurrent application of interferon-gamma and vincristine inhibits tumor growth in an orthotopic neuroblastoma mouse model.

机构信息

Department of Surgery, Stanford University, 453 Quarry Road, Palo Alto, CA, 94304, USA.

Department of Biomedical Engineering, Tufts University, 4 Colby Street, Medford, MA, 02155, USA.

出版信息

Pediatr Surg Int. 2023 Jul 27;39(1):241. doi: 10.1007/s00383-023-05523-w.

DOI:10.1007/s00383-023-05523-w
PMID:37500800
Abstract

PURPOSE

Tumor-associated macrophages are present within neuroblastoma, and interferon-gamma (IFN-γ) can polarize macrophages into cancer-inhibiting M1 type. We hypothesize that treating neuroblastoma with interferon-gamma (IFN-γ) can suppress tumor growth, and the concurrent treatment with IFN-γ and vincristine can lead to enhanced tumor killing as compared to vincristine alone.

METHODS

We loaded IFN-γ or vincristine into silk biomaterials and recorded the amount released over time. Orthotopic, syngeneic neuroblastoma xenografts were generated by injecting 9464D cells into adrenal gland of C57BL/6 mice, and IFN-γ-loaded and/or vincristine-loaded silk biomaterials were implanted into the tumor once the tumors reached 100 mm. Drug release at different timepoints was measured and tumor growth after different treatments were compared.

RESULTS

1-2% of IFN-γ and 70% of vincristine were released from the biomaterials by the fifth day. Combining IFN-γ and vincristine significantly slowed tumor growth as compared to the controls (12.2 ± 2.7 days to reach 800 mm versus 5.7 ± 1.2 days, p = 0.01), and IFN-γ alone also delayed tumor growth as compared to the controls (10.9 ± 1.5 days versus 5.7 ± 1.2 days, p = 0.001). Hematoxylin and eosin staining demonstrated tumor necrosis adjacent to the drug-loaded silk biomaterials.

CONCLUSION

Local delivery of sustained release IFN-γ can inhibit neuroblastoma tumor growth by itself and in combination with vincristine.

摘要

目的

神经母细胞瘤中存在肿瘤相关巨噬细胞,干扰素-γ(IFN-γ)可以将巨噬细胞极化为抑制癌症的 M1 型。我们假设用干扰素-γ(IFN-γ)治疗神经母细胞瘤可以抑制肿瘤生长,并且与单独使用长春新碱相比,IFN-γ 与长春新碱同时治疗可以导致更强的肿瘤杀伤作用。

方法

我们将 IFN-γ 或长春新碱载入丝素生物材料中,并记录随时间的释放量。通过将 9464D 细胞注射到 C57BL/6 小鼠的肾上腺中来生成原位、同基因神经母细胞瘤异种移植物,并且一旦肿瘤达到 100mm 就将 IFN-γ 负载和/或长春新碱负载的丝素生物材料植入肿瘤中。测量不同时间点的药物释放情况,并比较不同治疗后的肿瘤生长情况。

结果

第 5 天,生物材料中释放了 1-2%的 IFN-γ 和 70%的长春新碱。与对照组相比,联合使用 IFN-γ 和长春新碱显著减缓了肿瘤生长(达到 800mm 的时间为 12.2±2.7 天,而对照组为 5.7±1.2 天,p=0.01),并且与对照组相比,IFN-γ 单独使用也延迟了肿瘤生长(达到 800mm 的时间为 10.9±1.5 天,而对照组为 5.7±1.2 天,p=0.001)。苏木精和伊红染色显示药物负载丝素生物材料附近的肿瘤坏死。

结论

局部持续释放 IFN-γ 可以单独或与长春新碱联合抑制神经母细胞瘤肿瘤生长。

相似文献

1
Concurrent application of interferon-gamma and vincristine inhibits tumor growth in an orthotopic neuroblastoma mouse model.γ干扰素和长春新碱的同时应用抑制原位神经母细胞瘤小鼠模型中的肿瘤生长。
Pediatr Surg Int. 2023 Jul 27;39(1):241. doi: 10.1007/s00383-023-05523-w.
2
Enhancing sustained-release local therapy: Single versus dual chemotherapy for the treatment of neuroblastoma.增强持续释放局部治疗:单一与双重化疗治疗神经母细胞瘤。
Surgery. 2020 Jun;167(6):969-977. doi: 10.1016/j.surg.2020.01.012. Epub 2020 Feb 28.
3
Disseminated injection of vincristine-loaded silk gel improves the suppression of neuroblastoma tumor growth.载长春新碱的丝凝胶弥散注射可提高神经母细胞瘤肿瘤生长抑制率。
Surgery. 2018 Oct;164(4):909-915. doi: 10.1016/j.surg.2018.06.017. Epub 2018 Jul 27.
4
Implantable chemotherapy-loaded silk protein materials for neuroblastoma treatment.用于神经母细胞瘤治疗的可植入载化疗药物丝蛋白材料。
Int J Cancer. 2017 Feb 1;140(3):726-735. doi: 10.1002/ijc.30479. Epub 2016 Nov 3.
5
Local delivery of dinutuximab from lyophilized silk fibroin foams for treatment of an orthotopic neuroblastoma model.丝素蛋白冻干泡沫局部递送达妥昔单抗治疗原位神经母细胞瘤模型。
Cancer Med. 2020 Apr;9(8):2891-2903. doi: 10.1002/cam4.2936. Epub 2020 Feb 24.
6
Manipulation of variables in local controlled release vincristine treatment in neuroblastoma.神经母细胞瘤局部控释长春新碱治疗中变量的操控
J Pediatr Surg. 2017 Dec;52(12):2061-2065. doi: 10.1016/j.jpedsurg.2017.08.028. Epub 2017 Sep 4.
7
Controlled release of cytokines using silk-biomaterials for macrophage polarization.使用丝基生物材料控制细胞因子释放以实现巨噬细胞极化
Biomaterials. 2015 Dec;73:272-83. doi: 10.1016/j.biomaterials.2015.09.027. Epub 2015 Sep 21.
8
In vitro and in vivo evaluation of etoposide - silk wafers for neuroblastoma treatment.丝素载依托泊苷片的体内外评价用于神经母细胞瘤的治疗。
J Control Release. 2018 Sep 10;285:162-171. doi: 10.1016/j.jconrel.2018.07.002. Epub 2018 Jul 3.
9
Gamma-interferon and retinoic acid synergize in inhibiting the growth of human neuroblastoma cells in nude mice.γ-干扰素和视黄酸协同抑制裸鼠体内人神经母细胞瘤细胞的生长。
Cancer Lett. 1992 Jan 31;61(3):215-20. doi: 10.1016/0304-3835(92)90290-c.
10
Increased in vitro and in vivo tumoricidal activity of a macrophage cell line genetically engineered to express IFN-gamma, IL-4, IL-6, or TNF-alpha.经基因工程改造以表达干扰素-γ、白细胞介素-4、白细胞介素-6或肿瘤坏死因子-α的巨噬细胞系在体外和体内的杀瘤活性增强。
Cancer Gene Ther. 1995 Jun;2(2):113-24.

引用本文的文献

1
Evaluation of a Combinatorial Immunotherapy Regimen That Can Cure Mice Bearing MYCN-Driven High-Risk Neuroblastoma That Resists Current Clinical Therapy.一种可治愈携带MYCN驱动的、对当前临床治疗有抗性的高危神经母细胞瘤小鼠的联合免疫治疗方案的评估。
J Clin Med. 2024 Apr 26;13(9):2561. doi: 10.3390/jcm13092561.

本文引用的文献

1
Immune characterization of pre-clinical murine models of neuroblastoma.神经母细胞瘤临床前小鼠模型的免疫特征。
Sci Rep. 2020 Oct 7;10(1):16695. doi: 10.1038/s41598-020-73695-9.
2
Enhancing sustained-release local therapy: Single versus dual chemotherapy for the treatment of neuroblastoma.增强持续释放局部治疗:单一与双重化疗治疗神经母细胞瘤。
Surgery. 2020 Jun;167(6):969-977. doi: 10.1016/j.surg.2020.01.012. Epub 2020 Feb 28.
3
Combined innate and adaptive immunotherapy overcomes resistance of immunologically cold syngeneic murine neuroblastoma to checkpoint inhibition.
联合先天和适应性免疫疗法克服了免疫冷型同源鼠神经母细胞瘤对检查点抑制的耐药性。
J Immunother Cancer. 2019 Dec 6;7(1):344. doi: 10.1186/s40425-019-0823-6.
4
Macrophage-Derived IL1β and TNFα Regulate Arginine Metabolism in Neuroblastoma.巨噬细胞衍生的白细胞介素 1β和肿瘤坏死因子α调节神经母细胞瘤中的精氨酸代谢。
Cancer Res. 2019 Feb 1;79(3):611-624. doi: 10.1158/0008-5472.CAN-18-2139. Epub 2018 Dec 13.
5
Co-delivery of Doxorubicin and Interferon-γ by Thermosensitive Nanoparticles for Cancer Immunochemotherapy.热响应型纳米载药系统共递送多柔比星和干扰素-γ用于癌症免疫化学治疗
Mol Pharm. 2018 Sep 4;15(9):4161-4172. doi: 10.1021/acs.molpharmaceut.8b00564. Epub 2018 Jul 27.
6
Intratumoral Delivery of Interferonγ-Secreting Mesenchymal Stromal Cells Repolarizes Tumor-Associated Macrophages and Suppresses Neuroblastoma Proliferation In Vivo.瘤内递送分泌干扰素 γ 的间充质基质细胞重极化肿瘤相关巨噬细胞并抑制体内神经母细胞瘤增殖。
Stem Cells. 2018 Jun;36(6):915-924. doi: 10.1002/stem.2801. Epub 2018 Feb 27.
7
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy.癌症免疫疗法的原发性、适应性和获得性耐药性。
Cell. 2017 Feb 9;168(4):707-723. doi: 10.1016/j.cell.2017.01.017.
8
Tumour-associated macrophages as treatment targets in oncology.肿瘤相关巨噬细胞作为肿瘤治疗的靶点。
Nat Rev Clin Oncol. 2017 Jul;14(7):399-416. doi: 10.1038/nrclinonc.2016.217. Epub 2017 Jan 24.
9
Neuroblastoma.神经母细胞瘤。
Nat Rev Dis Primers. 2016 Nov 10;2:16078. doi: 10.1038/nrdp.2016.78.
10
Implantable chemotherapy-loaded silk protein materials for neuroblastoma treatment.用于神经母细胞瘤治疗的可植入载化疗药物丝蛋白材料。
Int J Cancer. 2017 Feb 1;140(3):726-735. doi: 10.1002/ijc.30479. Epub 2016 Nov 3.